Evidence map›Paper›PMID 32758126›Full record

ArticleBMC microbiology2020

Significant association between genes encoding virulence factors with antibiotic resistance and phylogenetic groups in community acquired uropathogenic Escherichia coli isolates.

Zahra Yazdanpour, Omid Tadjrobehkar, Motahareh Shahkhah

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Phylogenetic Group Distribution of UropathogenicFrontiers in cellular and infection microbiology · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Comparative genomic analysis ofMicrobial genomics · 2025
    Article
  7. Foods (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Third-Generation Cephalosporin-Resistant UropathogenicThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  13. Article
  14. Article
  15. Diagnostics (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Susceptibility and Virulence ofMicroorganisms · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Zahra YazdanpourMicrobiology and Parasitology Department, Medical Faculty, Zabol University of Medical Sciences, Zabol, Iran.
Omid TadjrobehkarBacteriology and Virology Department, Medical Faculty, Kerman University of Medical Sciences, Kerman, Iran. o.tadjrobehkar@gmail.com.ORCID 0000-0002-5562-8079
Motahareh ShahkhahMicrobiology Department, Medical Faculty, Zahedan University of Medical Sciences, Zahedan, Iran.
Kerman University of Medical Sciences · IRZabol University of Medical Sciences · IRZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntibiotic resistance is an increasing phenomenon in many bacterial pathogens including uropathogenic Escherichia coli. Hypothetical anti-virulent agents could be a solution, but first clear virulence associated gene-pool of antibiotic resistant isolates have to be determined. The aim of this study is to investigate the significant associations between genes encoding VFs with antibiotic resistance and phylogenetic groups in UPEC isolates.

resultsThe majority of 248 UPEC isolates belonged to phylogenetic group B2 (67.3%). The maximum and minimum resistance was attributed to amoxicillin (90.3%) and both fosfomycin and imipenem (1.6%) respectively. 11.3% of isolates were resistant to all antibiotic agents except that of imipenem, nitrofurantoin and fosfomycin. These highly resistant isolates were placed only in group B2 and D. The most prevalent virulence gene was ompA (93.5%). The hlyA was the only virulence gene that was significantly more prevalent in the highly resistant isolates. The ompA, malX and hlyA genes were obviously more abundant in the antibiotic resistant isolates in comparison to susceptible isolates. The papC gene was associated with amoxicillin resistance (p-value = 0.006, odds ratio: 26.00).

conclusionsIncreased resistance to first line drugs prescribed for UTIs were detected in CA-UPEC isolates in our study.. Minimal resistance was observed against nitrofurantoin, fosfomycin and imipenem. Therefore, they are introduced for application in empirical therapy of UTIs. Fosfomycin may be the most effective antibiotic agent against highly resistant UPEC isolates. The presence of the ompA, malX and hlyA genes were significantly associated with resistance to different antibiotic agents. We assume that the ability of UPEC isolates to upgrade their antibiotic resistance capacity may occurs in compliance with the preliminary existence of specific virulence associated genes. But, more investigation with higher number of bacterial isolates, further virulence associated genes and comparison of gene pools from CA-UPEC isolates with HA-UPEC are proposed to confirm these finding and discovering new aspects of this association.

Indexed as

PhylogenyAnti-Bacterial AgentsCommunity-Acquired InfectionsDrug Resistance, BacterialEscherichia coli InfectionsEscherichia coli ProteinsHumansUrinary Tract InfectionsUropathogenic Escherichia coliVirulenceVirulence FactorsAnti-Bacterial AgentsEscherichia coli ProteinsVirulence FactorsAntibiotic resistancePhylogenetic groupsUPECVirulence associated genes

Identifiers

PMID32758126
PMCPMC7409443
OpenAlexW3046985500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.